# Celator Pharmaceuticals Inc: Form D filings

Celator Pharmaceuticals Inc, a pharmaceuticals company in Princeton, NJ, filed 5 Form D notices with the SEC between 2010 and 2013. The latest, on May 13, 2013, reports $39.3 million sold of a $39.3 million offering to 306 investors.

Find out what Celator Pharmaceuticals Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Celator%20Pharmaceuticals%20Inc%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Celator%20Pharmaceuticals%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fcelator-pharmaceuticals-inc-1327467)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Celator%20Pharmaceuticals%20Inc%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Celator%20Pharmaceuticals%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fcelator-pharmaceuticals-inc-1327467)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey): 714 rows, by operating companies, filed since November 1, 2024, $35.70, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-jersey
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 303B COLLEGE ROAD EAST, Princeton, NJ, 08540
- Phone: (609) 243-0123
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: $1 - $1,000,000
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1327467

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 13, 2013 | Amendment | $39,262,788 | $39,262,788 | $0 | 306 | Aug 28, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1327467/000132746713000001/0001327467-13-000001-index.htm) |
| Aug 30, 2012 | New notice | $35,000,000 | $4,148,617 | $30,851,383 | 106 | Aug 28, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1327467/000132746712000001/0001327467-12-000001-index.htm) |
| Dec 28, 2011 | New notice | $5,000,500 | $2,576,867 | $2,423,633 | 10 | Dec 15, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1327467/000132746711000001/0001327467-11-000001-index.htm) |
| Sep 7, 2010 | New notice | $20,000,003 | $15,000,001 | $5,000,002 | 12 | Aug 25, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1327467/000132746710000004/0001327467-10-000004-index.htm) |
| May 10, 2010 | New notice | $2,500,000 | $2,500,000 | $0 | 9 | May 3, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1327467/000132746710000003/0001327467-10-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Lawrence T. Mayer | Executive Officer |  |
| Scott S. Morenstein | Director |  |
| Richard S. Kollender | Director |  |
| Fred M. Powell | Executive Officer |  |
| Joseph A. Mollica | Director |  |
| Alex S. Zisson | Director |  |
| Nicole S. Vitullo | Director |  |
| Jackson T. Scott | Executive Officer, Director |  |
| Kenneth A. Galbraith | Director |  |

## Other pharmaceuticals companies in New Jersey that filed recently

- [Grace Therapeutics, Inc.](https://specstream.ai/data/form-d/company/grace-therapeutics-inc-1444192) $10 million · Aug 11, 2026

[Every Form D from the week of May 13, 2013](https://specstream.ai/data/form-d/week/2013-05-13) · [All recent filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Celator Pharmaceuticals Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).